Previous Article | Next Article 
Molecular and Cellular Biology, September 2001, p. 5958-5969, Vol. 21, No. 17
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.17.5958-5969.2001
Signal Pathways Which Promote Invasion and Metastasis:
Critical and Distinct Contributions of Extracellular
Signal-Regulated Kinase and Ral-Specific Guanine Exchange
Factor Pathways
Yvona
Ward,1
Warner
Wang,1
Elisa
Woodhouse,2
Ilona
Linnoila,1
Lance
Liotta,2 and
Kathleen
Kelly1,*
Cell and Cancer Biology
Branch,1 and Laboratory of Pathology,
Center for Cancer Research,2 National Cancer
Institute, Bethesda, Maryland
Received 24 April 2001/Accepted 11 June 2001
Approximately 50% of metastatic tumors contain Ras mutations. Ras
proteins can activate at least three downstream signaling cascades
mediated by the Raf-MEK-extracellular signal-regulated kinase
family, phosphatidylinositol-3 (PI3) kinase, and Ral-specific guanine nucleotide exchange factors (RalGEFs). Here we investigated the
contribution of RalGEF and ERK activation to the development of
experimental metastasis in vivo and associated invasive properties in
vitro. Each pathway contributes distinct properties to the metastatic
phenotype. Following lateral tail vein injection, 3T3 cells transformed
by constitutively active Raf or MEK produced lung metastasis that
displayed circumscribed, noninfiltrating borders. In contrast, 3T3
cells transformed by Ras(12V,37G), a Ras effector mutant that activates
RalGEF but not Raf or P13 kinase, formed aggressive, infiltrative
metastasis. Dominant negative RalB inhibited Ras(12V,37G)-activated
invasion and metastasis, demonstrating the necessity of the RalGEF
pathway for a fully transformed phenotype. Moreover, 3T3 cells
constitutively expressing a membrane-associated form of RalGEF
(RalGDS-CAAX) formed invasive tumors as well, demonstrating that
activation of a RalGEF pathway is sufficient to initiate the invasive
phenotype. Despite the fact that Ras(12V,37G) expression does not
elevate ERK activity, inhibition of this kinase by a conditionally
expressed ERK phosphatase demonstrated that ERK activity was necessary
for Ras(12V,37G)-transformed cells to express matrix-degrading activity
in vitro and tissue invasiveness in vivo. Therefore, these experiments
have revealed a hitherto-unknown but essential interaction of the
RalGEF and ERK pathways to produce a malignant phenotype. The
generality of the role of the RalGEF pathway in metastasis is supported
by the finding that Ras(12V,37G) increased the invasiveness of
epithelial cells as well as fibroblasts.
*
Corresponding author. Mailing address: Building 10, Room 3B43, Bethesda, MD 20892. Phone: (301) 435-4651. Fax: (301)
435-4655. E-mail: kkelly{at}helix.nih.gov.
Molecular and Cellular Biology, September 2001, p. 5958-5969, Vol. 21, No. 17
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.17.5958-5969.2001
This article has been cited by other articles:
-
Li, T. T., Alemayehu, M., Aziziyeh, A. I., Pape, C., Pampillo, M., Postovit, L.-M., Mills, G. B., Babwah, A. V., Bhattacharya, M.
(2009). {beta}-Arrestin/Ral Signaling Regulates Lysophosphatidic Acid-Mediated Migration and Invasion of Human Breast Tumor Cells. Mol Cancer Res
7: 1064-1077
[Abstract]
[Full Text]
-
Lalli, G.
(2009). RalA and the exocyst complex influence neuronal polarity through PAR-3 and aPKC. J. Cell Sci.
122: 1499-1506
[Abstract]
[Full Text]
-
Phillips, J. M., Goodman, J. I.
(2008). Identification of Genes that May Play Critical Roles in Phenobarbital (PB)-Induced Liver Tumorigenesis due to Altered DNA Methylation. Toxicol Sci
104: 86-99
[Abstract]
[Full Text]
-
Quinlan, M. P., Quatela, S. E., Philips, M. R., Settleman, J.
(2008). Activated Kras, but Not Hras or Nras, May Initiate Tumors of Endodermal Origin via Stem Cell Expansion. Mol. Cell. Biol.
28: 2659-2674
[Abstract]
[Full Text]
-
de Gorter, D. J. J., Reijmers, R. M., Beuling, E. A., Naber, H. P. H., Kuil, A., Kersten, M. J., Pals, S. T., Spaargaren, M.
(2008). The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells. Blood
111: 3364-3372
[Abstract]
[Full Text]
-
Huang, D., Ding, Y., Luo, W.-M., Bender, S., Qian, C.-N., Kort, E., Zhang, Z.-F., VandenBeldt, K., Duesbery, N. S., Resau, J. H., Teh, B. T.
(2008). Inhibition of MAPK Kinase Signaling Pathways Suppressed Renal Cell Carcinoma Growth and Angiogenesis In vivo. Cancer Res.
68: 81-88
[Abstract]
[Full Text]
-
Yin, J., Pollock, C., Tracy, K., Chock, M., Martin, P., Oberst, M., Kelly, K.
(2007). Activation of the RalGEF/Ral Pathway Promotes Prostate Cancer Metastasis to Bone. Mol. Cell. Biol.
27: 7538-7550
[Abstract]
[Full Text]
-
Smith, S. C., Oxford, G., Baras, A. S., Owens, C., Havaleshko, D., Brautigan, D. L., Safo, M. K., Theodorescu, D.
(2007). Expression of Ral GTPases, Their Effectors, and Activators in Human Bladder Cancer. Clin. Cancer Res.
13: 3803-3813
[Abstract]
[Full Text]
-
Rajput, A., Koterba, A. P., Kreisberg, J. I., Foster, J. M., Willson, J. K.V., Brattain, M. G.
(2007). A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism In vivo. Cancer Res.
67: 665-673
[Abstract]
[Full Text]
-
Rosse, C., Hatzoglou, A., Parrini, M.-C., White, M. A., Chavrier, P., Camonis, J.
(2006). RalB Mobilizes the Exocyst To Drive Cell Migration. Mol. Cell. Biol.
26: 727-734
[Abstract]
[Full Text]
-
Oxford, G., Owens, C. R., Titus, B. J., Foreman, T. L., Herlevsen, M. C., Smith, S. C., Theodorescu, D.
(2005). RalA and RalB: Antagonistic Relatives in Cancer Cell Migration. Cancer Res.
65: 7111-7120
[Abstract]
[Full Text]
-
Cardone, R. A., Bagorda, A., Bellizzi, A., Busco, G., Guerra, L., Paradiso, A., Casavola, V., Zaccolo, M., Reshkin, S. J.
(2005). Protein Kinase A Gating of a Pseudopodial-located RhoA/ROCK/p38/NHE1 Signal Module Regulates Invasion in Breast Cancer Cell Lines. Mol. Biol. Cell
16: 3117-3127
[Abstract]
[Full Text]
-
Gallagher, P. E., Tallant, E.A.
(2004). Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis
25: 2045-2052
[Abstract]
[Full Text]
-
Colicelli, J.
(2004). Human RAS Superfamily Proteins and Related GTPases. Sci Signal
2004: re13-re13
[Abstract]
[Full Text]
-
Jimenez, M., de Castro, I. P., Benet, M., Garcia, J. F., Inghirami, G., Pellicer, A.
(2004). The Rgr Oncogene Induces Tumorigenesis in Transgenic Mice. Cancer Res.
64: 6041-6049
[Abstract]
[Full Text]
-
Schuierer, M. M., Bataille, F., Hagan, S., Kolch, W., Bosserhoff, A.-K.
(2004). Reduction in Raf Kinase Inhibitor Protein Expression Is Associated with Increased Ras-Extracellular Signal-Regulated Kinase Signaling in Melanoma Cell Lines. Cancer Res.
64: 5186-5192
[Abstract]
[Full Text]
-
Eckert, L. B., Repasky, G. A., Ulku, A. S., McFall, A., Zhou, H., Sartor, C. I., Der, C. J.
(2004). Involvement of Ras Activation in Human Breast Cancer Cell Signaling, Invasion, and Anoikis. Cancer Res.
64: 4585-4592
[Abstract]
[Full Text]
-
Takaya, A., Ohba, Y., Kurokawa, K., Matsuda, M.
(2004). RalA Activation at Nascent Lamellipodia of Epidermal Growth Factor-stimulated Cos7 Cells and Migrating Madin-Darby Canine Kidney Cells. Mol. Biol. Cell
15: 2549-2557
[Abstract]
[Full Text]
-
Rosse, C., L'Hoste, S., Offner, N., Picard, A., Camonis, J.
(2003). RLIP, an Effector of the Ral GTPases, Is a Platform for Cdk1 to Phosphorylate Epsin during the Switch Off of Endocytosis in Mitosis. J. Biol. Chem.
278: 30597-30604
[Abstract]
[Full Text]
-
Vos, M. D., Ellis, C. A., Elam, C., Ulku, A. S., Taylor, B. J., Clark, G. J.
(2003). RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor. J. Biol. Chem.
278: 28045-28051
[Abstract]
[Full Text]
-
Ramos-Nino, M. E., Scapoli, L., Martinelli, M., Land, S., Mossman, B. T.
(2003). Microarray Analysis and RNA Silencing Link fra-1 to cd44 and c-met Expression in Mesothelioma. Cancer Res.
63: 3539-3545
[Abstract]
[Full Text]
-
Fu, Z., Smith, P. C., Zhang, L., Rubin, M. A., Dunn, R. L., Yao, Z., Keller, E. T.
(2003). Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis. JNCI J Natl Cancer Inst
95: 878-889
[Abstract]
[Full Text]
-
Hu, Y., Mivechi, N. F.
(2003). HSF-1 Interacts with Ral-binding Protein 1 in a Stress-responsive, Multiprotein Complex with HSP90 in Vivo. J. Biol. Chem.
278: 17299-17306
[Abstract]
[Full Text]
-
Kawai, M., Kawashima, S., Sakoda, T., Toh, R., Kikuchi, A., Yamauchi-Takihara, K., Kunisada, K., Yokoyama, M.
(2003). Ral GDP Dissociation Stimulator and Ral GTPase Are Involved in Myocardial Hypertrophy. Hypertension
41: 956-962
[Abstract]
[Full Text]
-
Mirey, G., Balakireva, M., L'Hoste, S., Rosse, C., Voegeling, S., Camonis, J.
(2003). A Ral Guanine Exchange Factor-Ral Pathway Is Conserved in Drosophila melanogaster and Sheds New Light on the Connectivity of the Ral, Ras, and Rap Pathways. Mol. Cell. Biol.
23: 1112-1124
[Abstract]
[Full Text]
-
McFarlin, D. R., Lindstrom, M. J., Gould, M. N.
(2003). Affinity with Raf is sufficient for Ras to efficiently induce rat mammary carcinomas. Carcinogenesis
24: 99-105
[Abstract]
[Full Text]
-
Zhu, T., Ling, L., Lobie, P. E.
(2002). Identification of a JAK2-independent Pathway Regulating Growth Hormone (GH)-stimulated p44/42 Mitogen-activated Protein Kinase Activity. GH ACTIVATION OF Ral AND PHOSPHOLIPASE D IS Src-DEPENDENT. J. Biol. Chem.
277: 45592-45603
[Abstract]
[Full Text]
-
Hamad, N. M., Elconin, J. H., Karnoub, A. E., Bai, W., Rich, J. N., Abraham, R. T., Der, C. J., Counter, C. M.
(2002). Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev.
16: 2045-2057
[Abstract]
[Full Text]
-
Ward, Y., Yap, S.-F., Ravichandran, V., Matsumura, F., Ito, M., Spinelli, B., Kelly, K.
(2002). The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway. JCB
157: 291-302
[Abstract]
[Full Text]
-
Murphy, G. A., Graham, S. M., Morita, S., Reks, S. E., Rogers-Graham, K., Vojtek, A., Kelley, G. G., Der, C. J.
(2002). Involvement of Phosphatidylinositol 3-Kinase, but Not RalGDS, in TC21/R-Ras2-mediated Transformation. J. Biol. Chem.
277: 9966-9975
[Abstract]
[Full Text]
-
Ward, Y., Yap, S.-F., Ravichandran, V., Matsumura, F., Ito, M., Spinelli, B., Kelly, K.
(2002). The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway. JCB
157: 291-302
[Abstract]
[Full Text]